BioSpace News Archive

IQ4I Research & Consultancy published a new report on “Cell-Based Assays Global Market – Forecast To 2025".

HempWave announced that Eric Hutchings has joined its Board of Advisors.

Findings related to clinical safety and pharmacodynamic response together with evidence of activity in behavioral model of depression outlined in poster presentation

BioTalent Canada and Life Sciences Ontario announced the launch of The PetriDish™ Life Sciences Ontario job board, providing companies in one of Canada’s largest biotech hubs with a platform to attract talent.

Axial Biotherapeutics announced the publication of new findings in Cell by Sarkis K. Mazmanian, Ph.D., the Company’s scientific co-founder, and California Institute of Technology researchers, demonstrating that the colonization of germ-free mice with gut microbiota from human donors with Autism Spectrum Disorder (ASD) induces hallmark behaviors of ASD as compared to control, typically-developing (TD) gut microbiota.

Generation Bio, a company developing the first genetic medicines that can be re-dosed and titrated to effect for a lifetime of benefit, today announced that President and Chief Executive Officer, Geoff McDonough, will present a company update at the Jefferies 2019 Healthcare Conference in New York, NY.

The Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

GRAIL, Inc., a healthcare company focused on the early detection of cancer, today announced new data from the Circulating Cell-free Genome Atlas (CCGA) study that demonstrates the ability of GRAIL’s technology to detect cancer early with a single blood test.

Canada is failing its youth when it comes to tobacco control, according to a 2019 Report, released by the Tobacco Endgame Cabinet.

Heritage Pharmaceuticals Inc. announced today that the Company has entered into a deferred prosecution agreement (“DPA”) with the United States Department of Justice, Antitrust Division (“DOJ”) relating to a one-count Information for a conspiracy involving glyburide. In conjunction with the DPA, Heritage will pay a $225,000 fine.